Literature DB >> 25459483

Risk factors for perioperative death in dogs undergoing splenectomy for splenic masses: 539 cases (2001-2012).

Kristin M Wendelburg1, Therese E O'Toole, Emily McCobb, Lori Lyn Price, Jeremiah A Lyons, John Berg.   

Abstract

OBJECTIVE: To determine the perioperative mortality rate, causes of death, and risk factors for perioperative death in dogs undergoing splenectomy for splenic mass lesions.
DESIGN: Retrospective case series. ANIMALS: 539 dogs. PROCEDURES: Medical records of dogs that underwent splenectomy for known splenic masses were reviewed. Perioperative mortality rate and causes of death were determined. Associations between potential prognostic factors and perioperative death were evaluated by multivariable logistic regression analysis.
RESULTS: 41 of 539 (7.6%) dogs died during the perioperative period. Thrombotic and coagulopathic syndromes and uncontrolled bleeding from metastatic lesions were the most common causes of death. Of the variables selected for multivariable analysis, platelet count at admission, whether PCV at admission was < 30%, and development of ventricular arrhythmias during surgery were significantly associated with outcome. For each decrease in platelet count of 10,000 platelets/μL, odds of death increased by approximately 6%. For dogs with PCV < 30%, odds of death were approximately twice those for dogs with PCV ≥ 30%, and for dogs that developed intraoperative arrhythmias, odds of death were approximately twice those for dogs that did not. CONCLUSIONS AND CLINICAL RELEVANCE: Marked preoperative thrombocytopenia or anemia and development of intraoperative ventricular arrhythmias were identified as risk factors for perioperative death in dogs with splenic masses. The risk of death may be limited by efforts to prevent thrombotic and coagulopathic syndromes and to control all sources of intra-abdominal hemorrhage.

Entities:  

Mesh:

Year:  2014        PMID: 25459483     DOI: 10.2460/javma.245.12.1382

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Epidemiology and Survival of Dogs Diagnosed with Splenic Lymphoid Hyperplasia, Complex Hyperplasia, Stromal Sarcoma and Histiocytic Sarcoma.

Authors:  Cleide H Spröhnle-Barrera; Jayne McGhie; Rachel E Allavena; Helen C Owen; Chiara Palmieri; Tamsin S Barnes
Journal:  Animals (Basel)       Date:  2022-04-08       Impact factor: 3.231

2.  Presurgical assessment of splenic tumors in dogs: a retrospective study of 57 cases (2012-2017).

Authors:  Mokhyeon Lee; Jiyoung Park; Hojung Choi; Haebeom Lee; Seong Mok Jeong
Journal:  J Vet Sci       Date:  2018-11-30       Impact factor: 1.672

3.  Evaluation of cytological diagnostic accuracy for canine splenic neoplasms: An investigation in 78 cases using STARD guidelines.

Authors:  Marco Tecilla; Matteo Gambini; Annalisa Forlani; Mario Caniatti; Gabriele Ghisleni; Paola Roccabianca
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

4.  Pre-operative Hemostatic Status in Dogs Undergoing Splenectomy for Splenic Masses.

Authors:  Jourdan B McPhetridge; Alex M Lynch; Cynthia R L Webster; Emily McCobb; A M de Laforcade; Therese E O'Toole
Journal:  Front Vet Sci       Date:  2022-04-25

5.  Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma.

Authors:  Alison R Masyr; Aaron K Rendahl; Amber L Winter; Antonella Borgatti; Jaime F Modiano
Journal:  J Am Vet Med Assoc       Date:  2021-03-15       Impact factor: 1.936

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.